The pathways involved mainly include cancer pathways, PI3K-AKT signaling pathway, EGFR tyrosine kinase inhibitor resistance, fluid shear stress and atherosclerosis, AGE-RAGE signaling pathway in diabetic complications, hepatitis B, etc. (Table 7). This evidence concerns the gene PIK3CA and cancer.